Clinical Trial

Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.

Study acronym: Post-ERCP
Completed Phase 3
View on ClinicalTrials.gov →
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is a key procedure for managing biliopancreatic diseases, although it is associated with complications such as post-ERCP pancreatitis. This study assessed the efficacy of a prophylactic protocol combining rectal indomethacin with aggressive hydration to reduce the incidence of post-ERCP pancreatitis and serum amylase and lipase levels.
Trial Details
NCT Number NCT07599605
Lead Sponsor Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
Conditions Pancreatitis, ERCP
Enrollment 60 participants
Start Date 2024-03-04
Primary Completion 2024-12-27 (estimated)
Study Completion 2025-01-17 (estimated)
Updated on ClinicalTrials.gov 2026-05-20